Quest Diagnostics IncorporatedDGXNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank57
3Y CAGR+2.6%
5Y CAGR-4.9%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+2.6%/yr
vs -0.3%/yr prior
5Y CAGR
-4.9%/yr
Recent acceleration
Acceleration
+2.9pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 19.88% | +3.6% |
| 2024 | 19.19% | +2.5% |
| 2023 | 18.72% | +1.7% |
| 2022 | 18.42% | -37.1% |
| 2021 | 29.28% | +14.6% |
| 2020 | 25.55% | +24.5% |
| 2019 | 20.52% | +10.0% |
| 2018 | 18.64% | -1.1% |
| 2017 | 18.85% | -4.2% |
| 2016 | 19.68% | - |